Filed: 2/13/2024ACC: 0001974915-24-000002
📋 What this filing means
VESTAL POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 48 equity positions with a total reported market value of $943.96M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
48
Positions
$943.96M
Total AUM (reported)
41.35M
Total Shares
Allocation by class
COM$596.80M63.2%
SPONSORED ADR$110.48M11.7%
SHS USD$89.17M9.4%
SHS$48.69M5.2%
CL A$42.63M4.5%
COM PAR $.01$27.89M3.0%
COM NEW$16.71M1.8%
Portfolio Concentration
Top 3$273.30M29.0%
4–10$308.55M32.7%
11–25$284.81M30.2%
Rest$77.30M8.2%
Top 3 weight
29.0%
Top 10 weight
61.6%
Voting Authority Distribution
Total shares with voting rights: 41.35M
Sole
Full voting authority
41.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole48
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings48
Rows:
Neurocrine Biosciences Inc
SOLEShares800K
TypeSH
Market value$105.41M
11.17%
Sole
800K
Shared
0.00
None
0.00
Jazz Pharmaceuticals PLC
SOLEShares725K
TypeSH
Market value$89.17M
9.45%
Sole
725K
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares625K
TypeSH
Market value$78.72M
8.34%
Sole
625K
Shared
0.00
None
0.00
Inhibrx Inc
SOLEShares1.53M
TypeSH
Market value$58.14M
6.16%
Sole
1.53M
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares1.30M
TypeSH
Market value$52.33M
5.54%
Sole
1.30M
Shared
0.00
None
0.00
Merck & Co Inc
SOLEShares400K
TypeSH
Market value$43.61M
4.62%
Sole
400K
Shared
0.00
None
0.00
Globus Medical Inc
SOLEShares800K
TypeSH
Market value$42.63M
4.52%
Sole
800K
Shared
0.00
None
0.00
Pacira BioSciences Inc
SOLEShares1.20M
TypeSH
Market value$40.49M
4.29%
Sole
1.20M
Shared
0.00
None
0.00
Cymabay Therapeutics Inc
SOLEShares1.63M
TypeSH
Market value$38.38M
4.07%
Sole
1.63M
Shared
0.00
None
0.00
Vaxcyte Inc
SOLEShares525K
TypeSH
Market value$32.97M
3.49%
Sole
525K
Shared
0.00
None
0.00
Insmed Inc
SOLEShares900K
TypeSH
Market value$27.89M
2.95%
Sole
900K
Shared
0.00
None
0.00
uniQure NV
SOLEShares3.92M
TypeSH
Market value$26.57M
2.81%
Sole
3.92M
Shared
0.00
None
0.00
ALX Oncology Holdings Inc
SOLEShares1.66M
TypeSH
Market value$24.64M
2.61%
Sole
1.66M
Shared
0.00
None
0.00
Immatics NV
SOLEShares2.10M
TypeSH
Market value$22.11M
2.34%
Sole
2.10M
Shared
0.00
None
0.00
Viridian Therapeutics Inc
SOLEShares1M
TypeSH
Market value$21.78M
2.31%
Sole
1M
Shared
0.00
None
0.00
REVOLUTION Medicines Inc
SOLEShares725K
TypeSH
Market value$20.79M
2.20%
Sole
725K
Shared
0.00
None
0.00
Biogen Inc
SOLEShares75K
TypeSH
Market value$19.41M
2.06%
Sole
75K
Shared
0.00
None
0.00
Edwards Lifesciences Corp
SOLEShares225K
TypeSH
Market value$17.16M
1.82%
Sole
225K
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares250K
TypeSH
Market value$16.84M
1.78%
Sole
250K
Shared
0.00
None
0.00
Crinetics Pharmaceuticals Inc
SOLEShares450K
TypeSH
Market value$16.01M
1.70%
Sole
450K
Shared
0.00
None
0.00
Lyra Therapeutics Inc
SOLEShares3M
TypeSH
Market value$15.72M
1.67%
Sole
3M
Shared
0.00
None
0.00
Sanofi SA
SOLEShares300K
TypeSH
Market value$14.92M
1.58%
Sole
300K
Shared
0.00
None
0.00
Nuvalent Inc
SOLEShares200K
TypeSH
Market value$14.72M
1.56%
Sole
200K
Shared
0.00
None
0.00
Applied Therapeutics Inc
SOLEShares4.16M
TypeSH
Market value$13.92M
1.47%
Sole
4.16M
Shared
0.00
None
0.00
Liquidia Corp
SOLEShares1.02M
TypeSH
Market value$12.33M
1.31%
Sole
1.02M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Neurocrine Biosciences IncSOLE | COM | 800K | SH | $105.41M 11.17% | 800K | 0.00 | 0.00 |
Jazz Pharmaceuticals PLCSOLE | SHS USD | 725K | SH | $89.17M 9.45% | 725K | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 625K | SH | $78.72M 8.34% | 625K | 0.00 | 0.00 |
Inhibrx IncSOLE | COM | 1.53M | SH | $58.14M 6.16% | 1.53M | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | COM | 1.30M | SH | $52.33M 5.54% | 1.30M | 0.00 | 0.00 |
Merck & Co IncSOLE | COM | 400K | SH | $43.61M 4.62% | 400K | 0.00 | 0.00 |
Globus Medical IncSOLE | CL A | 800K | SH | $42.63M 4.52% | 800K | 0.00 | 0.00 |
Pacira BioSciences IncSOLE | COM | 1.20M | SH | $40.49M 4.29% | 1.20M | 0.00 | 0.00 |
Cymabay Therapeutics IncSOLE | COM | 1.63M | SH | $38.38M 4.07% | 1.63M | 0.00 | 0.00 |
Vaxcyte IncSOLE | COM | 525K | SH | $32.97M 3.49% | 525K | 0.00 | 0.00 |
Insmed IncSOLE | COM PAR $.01 | 900K | SH | $27.89M 2.95% | 900K | 0.00 | 0.00 |
uniQure NVSOLE | SHS | 3.92M | SH | $26.57M 2.81% | 3.92M | 0.00 | 0.00 |
ALX Oncology Holdings IncSOLE | COM | 1.66M | SH | $24.64M 2.61% | 1.66M | 0.00 | 0.00 |
Immatics NVSOLE | SHS | 2.10M | SH | $22.11M 2.34% | 2.10M | 0.00 | 0.00 |
Viridian Therapeutics IncSOLE | COM | 1M | SH | $21.78M 2.31% | 1M | 0.00 | 0.00 |
REVOLUTION Medicines IncSOLE | COM | 725K | SH | $20.79M 2.20% | 725K | 0.00 | 0.00 |
Biogen IncSOLE | COM | 75K | SH | $19.41M 2.06% | 75K | 0.00 | 0.00 |
Edwards Lifesciences CorpSOLE | COM | 225K | SH | $17.16M 1.82% | 225K | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 250K | SH | $16.84M 1.78% | 250K | 0.00 | 0.00 |
Crinetics Pharmaceuticals IncSOLE | COM | 450K | SH | $16.01M 1.70% | 450K | 0.00 | 0.00 |
Lyra Therapeutics IncSOLE | COM | 3M | SH | $15.72M 1.67% | 3M | 0.00 | 0.00 |
Sanofi SASOLE | SPONSORED ADR | 300K | SH | $14.92M 1.58% | 300K | 0.00 | 0.00 |
Nuvalent IncSOLE | COM | 200K | SH | $14.72M 1.56% | 200K | 0.00 | 0.00 |
Applied Therapeutics IncSOLE | COM | 4.16M | SH | $13.92M 1.47% | 4.16M | 0.00 | 0.00 |
Liquidia CorpSOLE | COM NEW | 1.02M | SH | $12.33M 1.31% | 1.02M | 0.00 | 0.00 |
Page 1 of 2